zalutumumab
Showing 1 - 9 of 9
Head Neck Cancer Trial in Aarhus (Radiotherapy, Zalutumumab)
Completed
- Cancer of the Head and Neck
- Radiotherapy
- Zalutumumab
-
Aarhus, DenmarkDepartment of Experimental Clinical Oncology, Aarhus University
Nov 22, 2016
Head Neck Cancer, Squamous Cell Cancer Trial in Worldwide (Zalutumumab)
Completed
- Head and Neck Cancer
- Squamous Cell Cancer
- Zalutumumab
-
Birmingham, Alabama
- +47 more
Aug 12, 2014
Head Neck Cancer, Squamous Cell Cancer Trial in Worldwide (Zalutumumab, Control)
Completed
- Head and Neck Cancer
- Squamous Cell Cancer
- Zalutumumab
- Control
-
Antwerp, Belgium
- +81 more
Aug 9, 2013
Head and Neck Tumors Trial in Denmark, Sweden (Zalutumumab)
Completed
- Head and Neck Neoplasms
- Zalutumumab
-
Copenhagen Ø, Denmark
- +4 more
Nov 17, 2011
Head Neck Cancer, Squamous Cell Cancer Trial in Worldwide (zalutumumab, cisplatin, Radiotherapy)
Terminated
- Head and Neck Cancer
- Squamous Cell Cancer
- zalutumumab
- +2 more
-
Portland, Oregon
- +6 more
Nov 21, 2011
Head Neck Cancer, Squamous Cell Carcinoma Trial in Belgium, France, United Kingdom (Zalutumumab)
Terminated
- Head and Neck Cancer
- Squamous Cell Carcinoma
- Zalutumumab
-
Brussels, Belgium
- +7 more
Nov 21, 2011
Non Small Cell Lung Cancer Trial in Worldwide (biological, drug, radiation)
Terminated
- Non Small Cell Lung Cancer
- Zalutumumab
- +2 more
-
Towson, Maryland
- +7 more
Dec 5, 2011
NSCLC Trial (zalutumumab)
Withdrawn
- Non-small Cell Lung Cancer
- zalutumumab
- (no location specified)
Oct 7, 2011